Skip to main content

Briacell Therapeutics Corp(BCT-T)
TSX

Today's Change
Real-Time Last Update
Volume

Latest News

Briacell Therapeutics Corp stock advanced on Friday.
The Globe and Mail - Fri Jun 24, 3:13PM CDT
The Globe and Mail
Fri Jun 24, 3:13PM CDT
BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
Globe Newswire - Fri Jun 24, 8:00AM CDT
Globe Newswire
Fri Jun 24, 8:00AM CDT
Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication....
Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days
Business Wire - Sun Jun 5, 6:52AM CDT
Business Wire
Sun Jun 5, 6:52AM CDT
Creatv Bio, Division of Creatv MicroTech, Inc., announced today the release of an abstract featuring the results of its LifeTracDx® blood test for predicting response of metastatic breast cancer (mBC) to new lines of therapy following a single...
BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment
Globe Newswire - Wed May 18, 8:15AM CDT
Globe Newswire
Wed May 18, 8:15AM CDT
PHILADELPHIA and VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
Stocks in play: BriaCell Therapeutics Corp.
Baystreet - Wed Apr 13, 8:54AM CDT
Baystreet
Wed Apr 13, 8:54AM CDT
Announced that the U.S. Food and Drug Administration has granted Fast Track status to BriaCell’s lead ...
BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
Globe Newswire - Wed Apr 13, 7:00AM CDT
Globe Newswire
Wed Apr 13, 7:00AM CDT
U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, Bria-IMT™, for the treatment of metastatic breast...
BriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022
Globe Newswire - Tue Apr 12, 3:30PM CDT
Globe Newswire
Tue Apr 12, 3:30PM CDT
Based on clinical data with Bria-IMT™, BriaCell has developed Bria-OTS™, an off-the-shelf (i.e. pre-manufactured) personalized immunotherapy.Bria-OTS™ will...
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
Globe Newswire - Thu Apr 7, 7:30AM CDT
Globe Newswire
Thu Apr 7, 7:30AM CDT
Bria-OTS™ would build on BriaCell’s existing clinical trial data with Bria-IMT™, treating each patient with the optimized pre-manufactured Bria-OTS™...
Stocks in play: BriaCell Therapeutics Corp.
Baystreet - Mon Feb 28, 9:44AM CST
Baystreet
Mon Feb 28, 9:44AM CST
Has recruited two additional clinical sites for screening and enrolling advanced breast cancer patients ...
BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board
Globe Newswire - Wed Feb 23, 7:00AM CST
Globe Newswire
Wed Feb 23, 7:00AM CST
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...